Impact of dry ejaculation caused by highly selective α1a-blocker: Randomized, double-blind, placebo-controlled crossover pilot study in healthy volunteer men

Journal of Sexual Medicine

Volumn 7, Issue 3, 2010, Pages 1277-1283

  Shimizu, Fumitaka ^a   Taguri, Masataka ^b   Harada, Yoshiko ^c   Matsuyama, Yutaka ^b   Sase, Kazuhiro ^a   Fujime, Makoto ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JUNTENDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Alpha blockers; Ejaculation; Ejaculatory disorder; Orgasm; Silodosin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PLACEBO; SILODOSIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS CAVERNOSUM; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; EJACULATION DISORDER; HUMAN; HUMAN EXPERIMENT; MALE; MASTURBATION; MUSCLE CONTRACTION; NORMAL HUMAN; ORGASM; PELVIS FLOOR; PILOT STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SEMEN ANALYSIS; SINGLE DRUG DOSE; URETHRA;

EID: 77950851567     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01663.x     Document Type: Article

References (35)

1. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003, 170:530-47. AUA Practice Guidelines Committee
2. Kojima Y, Sasaki S, Shinoura H, Hayashi Y, Tsujimoto G, Kohri K. Quantification of alpha1-adrenoceptor subtypes by real-time RT-PCR and correlation with age and prostate volume in benign prostatic hyperplasia patients. Prostate 2006, 66:761-7.
3. Debruyne FM. Alpha blockers: Are all created equal? Urology 2000, 56:20-2.
4. Hisasue S, Furuya R, Itoh N, Kobayashi K, Furuya S, Tsukamoto T. Ejaculatory disorder caused by alpha-1 adrenoceptor antagonists is not retrograde ejaculation but a loss of seminal emission. Int J Urol 2006, 13:1311-6.
5. Hellstrom WJ, Sikka SC. Effects of acute treatment with tamsulosin versus alfuzosin of ejaculatory function in normal volunteers. J Urol 2006, 176:1529-33.
6. Walden PD, Durkin MM, Lepor H, Wetzel JM, Gluchowski C, Gustafson EL. Localization of mRNA and receptor binding sites for the α1a-adrenoceptor subtype in the rat, monkey and human urinary bladder and prostate. J Urol 1997, 157:1032-8.
7. Scofield MA, Liu F, Abel PW, Jeffries WB. Quantification of steady state expression of mRNA for alpha-1 adrenergic receptor subtypes using reverse transcription and a competitive polymerase chain reaction. J Pharmacol Exp Ther 1995, 275:1035-42.
8. Moriyama N, Nasu K, Takeuchi T, Akiyama K, Murata S, Nishimatsu H, Yano J, Tsujimoto G, Kawabe K. Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human vas deferens: Comparison with those of epididymal and pelvic portions. Br J Pharmacol 1997, 122:1009-14.
9. Sanbe A, Tanaka Y, Fujiwara Y, Tsumura H, Yamauchi J, Cotecchia S, Koike K, Tsujimoto G, Tanoue AM. 1-Adrenoceptors are required for normal male sexual function. Br J Pharmacol 2007, 152:332-40.
10. Steers WD, Andersson KE. Neuroanatomy and physiology of the prostate. Prostatic diseases 2000, 28-40. Lepor H, In, ed, Philadelphia, PA, W.B. Saunders Company
11. Donatucci CF. Etiology of ejaculation and pathophysiology of premature ejaculation. J Sex Med 2006, 3(4):303-8. suppl
12. Hellstrom WJ. Current and future pharmacotherapies of premature ejaculation. J Sex Med 2006, 3(4):332-41. suppl
13. de Jong TR, Veening JG, Olivier B, Waldinger MD. Oxytocin involvement in SSRI-induced delayed ejaculation: A review of animal studies. J Sex Med 2007, 4:14-28.
14. Andersson KE, Wyllie MG. Ejaculatory dysfunction: Why all alpha-blockers are not equal. BJU Int 2003, 92:876-7.
15. Kobayashi K, Masumori N, Hisasue S, Kato R, Hashimoto K, Itoh N, Tsukamoto T. Inhibition of seminal emission is the main cause of anejaculation induced by a new highly selective α1A-blocker in normal volunteers. J Sex Med 2008, 5:2185-90.
16. Chen Y, Li H, Dong Q, Wang KJ. Blockade of alpha 1A-adrenoceptor: A novel possible strategy for male contraception. Med Hypotheses 2009, 73:140-1.
17. Noguchi Y, Ohtake A, Suzuki M, Sasamata M. In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs. Eur J Pharmacol 2008, 580:256-61.
18. Muto S, Kasahara H, Yokoi R, Hayashi M, Souma S, Kobayashi K, Tamura T, Murakami M, Kuroda J, Shibata N. Toxicity profile of silodosin (KMD-3213). Yakugaku Zasshi 2006, 126:247-56. Spec no.
19. Georgiadis JR, Reinders AA, Paans AM, Renken R, Kortekaas R. Men versus women on sexual brain function: Prominent differences during tactile genital stimulation, but not during orgasm. Hum Brain Mapp 2009, 30:3089-101.
20. Jannini EA, Simonelli C, Lenzi A. Disorders of ejaculation. J Endocrinol Invest 2002, 25:1006-19.
21. Koeman M, van Driel MF, Schultz WC, Mensink HJ. Orgasm after radical prostatectomy. Br J Urol 1996, 77:861-64.
22. Barnas JL, Pierpaoli S, Ladd P, Valenzuela R, Aviv N, Parker M, Waters WB, Flanigan RC, Mulhall JP. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int 2004, 94:603-5.
23. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001, 94:149-58.
24. Matsuyama Y. Correcting for non-compliance of repeated outcomes in randomized clinical trials: Randomized analysis approach. Stat Med 2002, 21:675-87.
25. Gil-Vernet JM, Alvarez-Vijande R, Gil-Vernet A, Gil-Vernet JM. Ejaculation in men: A dynamic endorectal ultrasonographical study. Br J Urol 1994, 73:442-8.
26. Bohlen D, Hugonnet CL, Mills RD, Weise ES, Schmid HP. Five meters of H(2)O: The pressure at the urinary bladder neck during human ejaculation. Prostate 2000, 44:339-41.
27. Courtois F, Charvier K, Leriche A, Vézina JG, Côté I, Raymond D, Jacquemin G, Fournier C, Bélanger M. Perceived physiological and orgasmic sensations at ejaculation in spinal cord injured men. J Sex Med 2008, 5:2419-30.
28. Soler JM, Previnaire JG, Plante P, Denys P, Chartier-Kastler E. Midodrine improves orgasm in spinal cord-injured men: The effects of autonomic stimulation. J Sex Med 2008, 5:2935-41.
29. Krüger TH, Hartmann U, Schedlowski M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol 2005, 23:130-8.
30. Gan M, Smit M, Dohle GR, Bosch JL, Bohnen A. Determinants of ejaculatory dysfunction in a community based longitudinal study. BJU Int 2007, 99:1443-8.
31. Gerstenberg TC, Levin RJ, Wagner G. Erection and ejaculation in man. Assessment of the electromyographic activity of the bulbocavernosus and ischiocavernosus muscles. Br J Urol 1990, 65:395-402.
32. Nagai A, Hara R, Yokoyama T, Jo Y, Fujii T, Miyaji Y. Ejaculatory dysfunction caused by the new alpha1-blocker silodosin: A preliminary study to analyze human ejaculation using color Doppler ultrasonography. Int J Urol 2008, 15:915-8.
33. Shafik A, El-Sibai O. Mechanism of ejection during ejaculation: Identification of a urethrocavernosus reflex. Arch Androl 2000, 44:77-83.
34. Lue TM. Physiology of penile erection and pathophysiology of erectile dysfunction. Campbell-Walsh urology 2007, 718-49. Kavoussi LRNovick ACPartin AWPeters CAWein AJ. In, eds, 9th, edition, Philadelphia, PA, Saunders Company
35. Sigman M, Jarow JP. Male infertility. Campbell-Walsh urology 2007, 609-53. Kavoussi LR, Novick ACPartin AWPeters CAWein AJ. In, eds, 9th, edition, Philadelphia, PA, Saunders Company